SARAH MADDEN: Open Payments
NPI 1235511619 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$779 in 21 payments from 12 companies in 2025. Trend: 2023 $572 · 2024 $370 · 2025 $779
Food & beverage: $484Travel & lodging: $295
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 2 | $295 |
| Calliditas Therapeutics US Inc. | 4 | $123 |
| Otsuka America Pharmaceutical, Inc. | 3 | $73 |
| Travere Therapeutics, Inc. | 3 | $65 |
| GENZYME CORPORATION | 1 | $47 |
| SCPHARMACEUTICALS INC. | 2 | $45 |
| Recor Medical Inc | 1 | $31 |
| Ardelyx, Inc. | 1 | $26 |
| Amgen Inc. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
Products named: Axonics, TARPEYO, JYNARQUE, FABRAZYME, FUROSCIX, Paradise Ultrasound Renal Denervation System, IBSRELA, TAVNEOS.
Industry payments across SC — which companies pay providers there.
